Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium valproate in adults with McArdle disease
2012-002933-12Phase 2Completed
- Sponsor
- University College London
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of divalproex sodium in glycogen storage disease type V (GSDV), sponsored by University College London. Primary endpoints: Exercise endurance on cycle ergometer and Muscle biopsy fibre normalization. Started Apr 2014; status: completed.
02
Drugs
divalproex sodium
03
Conditions
glycogen storage disease type V (GSDV)
Beyond the preview
Go deeper on 2012-002933-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002933-12.